CHAMPIONS ONCOLOGY, INC. (CSBR) Operating income 2017–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) annual operating income history from SEC filings — each fiscal year as reported.
-$1.1MFY2026 · since FY2017: -$6.8M → -$1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.1M | -125.0% |
| FY2025 | $4.6M | +161.9% |
| FY2024 | -$7.4M | -40.0% |
| FY2023 | -$5.3M | -965.9% |
| FY2022 | $607,000 | +65.8% |
| FY2021 | $366,000 | +119.1% |
| FY2020 | -$1.9M | -811.5% |
| FY2019 | $270,000 | +119.9% |
| FY2018 | -$1.4M | +80.1% |
| FY2017 | -$6.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating marginCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →